|
| |
Image Results
Loading...
Loading...
FARESTON Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
FARESTON (toremifene citrate) tablet [GTx, Inc.] - DailyMed: About ...
FARESTON (toremifene citrate) Tablets for oral administration each contain 88.5 mg of toremifene citrate, which is equivalent to 60 mg toremifene. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8888...
|
Toremifene citrate (Fareston).
Toremifene citrate (Fareston). Gerken P. Kansas City Cancer Center-South, Missouri, USA. Mesh Terms: Antineoplastic Agents, Hormonal/pharmacology ...
http://www.ncbi.nlm.nih.gov/pubmed/15565747...
|
Fareston (toremifene citrate) - US Food and Drug Administration ...
is promoting its product, Fareston, in violation of the Federal Food, Drug, and Cosmetic ... and median survival for Fareston versus tamoxifen patients. ...
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulat...
|
[Hormone therapy of advanced renal cancer with high-dose ...
Toremifene (Fareston)-a novel antiestrogenic drug with a triphenylethylene structure-has been effective in the treatment of postmenopausal breast cancer ...
http://www.ncbi.nlm.nih.gov/pubmed/9064893...
|
Toremifene
Fareston® (AR, AT, AU, BE, BR, CA, CH, CR, DE, DO, ES, FI, FR, GB, GT, HN, HU, IE, IT, LU, MX, NO, NZ, PA, PT, RO, RU, SE, SV, TH, YU) ...
http://www.umm.edu/altmed/drugs/toremifene-126404.htm...
|
Body mass index influences palpability but not stage of breast ...
BMI was calculated for patients in the North American Fareston and Tamoxifen Adjuvant trial, and was correlated with clinicopathologic factors, ...
http://www.ncbi.nlm.nih.gov/pubmed/17658091...
|
GTx, Inc. Reports Third Quarter 2009 Corporate Results - Yahoo ...
9 Nov 2009 ... Revenues included net sales of FARESTON® (toremifene citrate) 60 mg, marketed for the treatment of metastatic breast cancer in ...
http://biz.yahoo.com/bw/091109/20091109005308.html?.v=1...
|
Determinants of early distant metastatic disease in elderly ...
METHODS: We analyzed data from 938 patients in the North American Fareston Tamoxifen Adjuvant Trial>or=65 years old to determine predictors of early ...
http://www.ncbi.nlm.nih.gov/pubmed/16920425...
|
DOCKETS ENTERED on 04/16/99
97E-0357 Patent Extension; Fareston (toremifene citrate) 97E-0461 Patent Extension; Cook Incorporated Cook Grii Coronary Stent 97E-0462 Patent Extension; ...
http://www.fda.gov/ohrms/dockets/dailys/041699/041699.htm...
|
Toremifene - Wikipedia, the free encyclopedia
3 Jan 2009 ... Licensed in the United States under the brand name Fareston, toremifene citrate is FDA approved for use in advanced (metastatic) breast ...
http://en.wikipedia.org/wiki/Toremifene...
|
|